Kynam Capital Management, LP
Overview
Kynam Capital Management, LP is a private investment firm based in Princeton, New Jersey, specializing in healthcare and biotechnology investments. The firm employs a fundamental, research-driven approach, focusing on global healthcare markets and managing assets for institutional investors and high-net-worth individuals. Their investment strategy includes both long and short positions in publicly traded equities related to pharmaceutical preparations, aiming to generate alpha through deep industry knowledge and robust scientific and financial analysis. The firm's portfolio includes significant holdings in companies such as Celldex Therapeutics Inc., Natera Inc., and Syndax Pharmaceuticals Inc. Kynam Capital Management, LP has demonstrated active engagement in the biotechnology sector, with recent transactions including increasing stakes in Vera Therapeutics Inc. and Burning Rock Biotech Ltd., as well as reducing holdings in Cogent Biosciences Inc. These actions reflect the firm's strategic approach to portfolio management and its commitment to high-growth potential stocks in the biotechnology and healthcare sectors. Kynam Capital Management, LP was founded in 2020 and is led by Yue Tang, who serves as the Chief Compliance Officer and Managing Member. As of early 2025, the firm has approximately three employees. The firm's investment philosophy emphasizes capital protection, value investing, and alignment of interests, aiming to safeguard wealth while achieving long-term growth through investments in companies with durable competitive advantages acquired at attractive prices.
Investment Focus
- Accredited Investors Only
- Investment Horizon: 5-10 Years
- Focus on Healthcare and Biotechnology Sectors
- Preference for Companies with Durable Competitive Advantages
- Active Participation in Portfolio Companies
- Alignment of Interests with Investors
- Opportunistic, Sector-Specific Approach
- Emphasis on Capital Protection
- Long-Term Investment Perspective
Portfolio Companies
Reach Kynam Capital Management, LP directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Kynam Capital Management, LP
What sectors does Kynam Capital Management, LP invest in?
Kynam Capital Management, LP invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in New Jersey, United States. Kynam Capital Management, LP is listed as a private investment firm in the ConnectSafely investor database.
What stage does Kynam Capital Management, LP invest at?
Kynam Capital Management, LP backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 5M - 50M.
Which regions does Kynam Capital Management, LP invest in?
Kynam Capital Management, LP invests across United States, United Kingdom, Germany, China, Switzerland and Cayman Islands.
What companies has Kynam Capital Management, LP invested in?
Kynam Capital Management, LP's portfolio includes Natera Inc., MorphoSys AG, Celldex Therapeutics Inc., Syndax Pharmaceuticals Inc., Vera Therapeutics Inc., Burning Rock Biotech Ltd., Cogent Biosciences Inc. and Sutro Biopharma Inc..
Last updated · Source: ConnectSafely investor database

